Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pliant Therapeutics (PLRX) Shares Issued (2019 - 2023)

Historic Shares Issued for Pliant Therapeutics (PLRX) over the last 5 years, with Q1 2023 value amounting to $270.3 million.

  • Pliant Therapeutics' Shares Issued changed N/A to $270.3 million in Q1 2023 from the same period last year, while for Dec 2023 it was $270.3 million, marking a year-over-year increase of 2499.99%. This contributed to the annual value of $270.3 million for FY2023, which is 2499.99% up from last year.
  • According to the latest figures from Q1 2023, Pliant Therapeutics' Shares Issued is $270.3 million.
  • In the past 5 years, Pliant Therapeutics' Shares Issued ranged from a high of $270.3 million in Q1 2023 and a low of -$2.4 million during Q4 2021
  • In the last 5 years, Pliant Therapeutics' Shares Issued had a median value of $371000.0 in 2021 and averaged $44.9 million.
  • Per our database at Business Quant, Pliant Therapeutics' Shares Issued crashed by 1701428.57% in 2020 and then soared by 3069786.32% in 2022.
  • Pliant Therapeutics' Shares Issued (Quarter) stood at $28000.0 in 2019, then crashed by 8557.14% to -$2.4 million in 2020, then dropped by 3.17% to -$2.4 million in 2021, then soared by 8949.82% to $216.2 million in 2022, then rose by 25.0% to $270.3 million in 2023.
  • Its last three reported values are $270.3 million in Q1 2023, $216.2 million for Q3 2022, and -$2.4 million during Q4 2021.